Stockscreener 앱 받기
6.4012
0.15%
0.0788
전일 마감가:
$6.48
열려 있는:
$6.34
하루 거래량:
11,523
Relative Volume:
0.06
시가총액:
$3.71M
수익:
$49,300
순이익/손실:
$-6.27M
주가수익비율:
-0.7042
EPS:
-9.09
순현금흐름:
$-5.38M
1주 성능:
-3.13%
1개월 성능:
-7.55%
6개월 성능:
+33.54%
1년 성능:
-19.88%
1일 변동 폭
$6.30
$6.52
1주일 범위
$6.2901
$7.00
52주 변동 폭
$0.7425
$562.68
Aclarion Inc Stock (ACON) Company Profile
명칭
Aclarion Inc
전화
833 275 2266
주소
8181 ARISTA PLACE, BROOMFIELD
ACON을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
ACON
Aclarion Inc
|
6.4003 | 4.01M | 49,300 | -6.27M | -5.38M | -9.09 |
|
VEEV
Veeva Systems Inc
|
278.53 | 38.79B | 2.86B | 780.66M | 1.20B | 4.72 |
|
TEM
Tempus Ai Inc
|
64.53 | 11.40B | 803.32M | -709.10M | -212.68M | -7.8003 |
|
HQY
Healthequity Inc
|
101.36 | 8.76B | 1.15B | 96.70M | -161.99M | 1.09 |
|
DOCS
Doximity Inc
|
51.76 | 9.79B | 550.17M | 201.35M | 232.07M | 1.00 |
|
WAY
Waystar Holding Corp
|
39.42 | 6.77B | 906.14M | -52.62M | 89.62M | -0.3621 |
Aclarion Inc 주식(ACON)의 최신 뉴스
Aclarion (NASDAQ:ACON) Upgraded by Wall Street Zen to Hold Rating - Defense World
Aclarion stock price target cut to $20 at Ascendiant Capital By Investing.com - Investing.com India
Aclarion stock price target cut to $20 at Ascendiant Capital - Investing.com
Aclarion, Inc. (NASDAQ:ACON) Sees Large Drop in Short Interest - Defense World
Aclarion (NASDAQ:ACON) Trading Down 1.2% – Here’s Why - Defense World
Aclarion Announces Addition of Keck Medical Center of USC as CLARITY Trial Site - Ortho Spine News
USC Medical Center Joins Groundbreaking AI Trial to Revolutionize Chronic Back Pain Diagnosis - Stock Titan
Aclarion, Inc. SEC 10-Q Report - TradingView
Aclarion (ACON) Expands CLARITY Trial with Texas Back Institute - GuruFocus
Aclarion Announces Texas Back Institute as New CLARITY Trial Site - Ortho Spine News
Aclarion announces Texas Back Insitute as new CLARITY trial site - TipRanks
Aclarion Inc. Partners with Texas Back Institute for CLARITY Clinical Trial to Enhance Chronic Low Back Pain Treatment - Nasdaq
History Says Now Is the Time to Buy Nvidia Stock - The Globe and Mail
Aclarion Welcomes Advocate Health as CLARITY Trial Site - Ortho Spine News
Major Breakthrough: Advocate Health to Test AI-Powered Spine Pain Diagnostic in 300-Patient Trial - Stock Titan
Aclarion secures funding for pivotal CLARITY trial - MSN
Aclarion Announces Commercial Agreement with Spine Institute of Louisiana - Ortho Spine News
Aclarion (ACON) Partners with Louisiana Spine Institute to Expan - GuruFocus
Aclarion announces agreement with the Spine Institute of Louisiana - TipRanks
Aclarion Expands Nociscan Access with Commercial Agreement at Spine Institute of Louisiana - Nasdaq
Revolutionary Spine Pain Technology Nociscan Achieves 97% Success Rate, Expands to 17 Medical Centers - Stock Titan
Aclarion stock hits 52-week low at $7.25 amid steep annual decline By Investing.com - Investing.com South Africa
Aclarion stock hits 52-week low at $7.25 amid steep annual decline - Investing.com
Aclarion, Inc. (NASDAQ:ACON) Short Interest Update - Defense World
Aclarion Inc Files For Mixed Shelf Of Up To $150 MlnSEC Filing - marketscreener.com
Aclarion Releases Updated Investor Presentation at Showcase - TipRanks
Aclarion Releases Updated Investor Presentation in Connection with Appearance at Planet MicroCap Showcase: VEGAS 2025 - The Manila Times
Aclarion, Inc. to Present at Planet MicroCap Showcase: VEGAS 2025 on Chronic Low Back Pain Solutions - Nasdaq
Aclarion Releases Updated Investor Presentation in Connection with Appearance at Planet ... - Bluefield Daily Telegraph
Aclarion's Revolutionary AI Approach to Chronic Back Pain: New Investor Strategy Revealed at MicroCap Vegas - Stock Titan
3 Reasons to Buy Amazon Stock Like There's No Tomorrow - The Globe and Mail
Aclarion Announces Publication of Seminal Nociscan Cost-Effectiveness Analysis - Ortho Spine News
Aclarion's Nociscan Demonstrates Cost-Effectiveness and Improved Surgical Success Compared to Provocative Discography - Nasdaq
New Research: AI-Powered Spine Technology Cuts Patient Costs by $1,712, Boosts Surgery Success 10% - Stock Titan
NOCISCAN touted as lumbar pain diagnostic advance - MSN
12 Health Care Stocks Moving In Friday's After-Market Session - Benzinga
Aclarion to Present at the Planet MicroCap Showcase: VEGAS in Partnership with MicroCapClub - The Manila Times
Aclarion, Inc. SEC 10-K Report - TradingView
Aclarion stock hits 52-week low at $9.68 amid steep annual decline - Investing.com Canada
Aclarion stock hits 52-week low at $9.68 amid steep annual decline By Investing.com - Investing.com South Africa
Aclarion ‘s Nociscan now available in Santa Monica at MICSC - TipRanks
Aclarion Announces Expansion to Santa Monica with Medical Imaging Center of Southern California - The Manila Times
Revolutionary AI-Powered Back Pain Diagnostic Tool Gains Ground in Los Angeles Healthcare Market - Stock Titan
EXCLUSIVE: March's 20 Most-Searched Tickers On Benzinga Pro — Where Do Tesla, Nvidia, Apple, Applovin Stock Rank?Apple (NASDAQ:AAPL), Aclarion (NASDAQ:ACON) - Benzinga
Aclarion, Inc. Delays Annual Report Filing - TipRanks
Aclarion Provides Update on Strength of Company Positioning Following Q1 Strategic Initiatives - Ortho Spine News
Aclarion provides corporate update following Q1 strategic initiatives - TipRanks
Aclarion Inc (ACON) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.45%
0.62%
자본화:
|
볼륨(24시간):